BFLY vs. AORT, CDRE, NVCR, SSII, ESTA, MDXG, TNDM, PLSE, BLFS, and IRMD
Should you be buying Butterfly Network stock or one of its competitors? The main competitors of Butterfly Network include Artivion (AORT), Cadre (CDRE), NovoCure (NVCR), SS Innovations International (SSII), Establishment Labs (ESTA), MiMedx Group (MDXG), Tandem Diabetes Care (TNDM), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), and iRadimed (IRMD). These companies are all part of the "medical equipment" industry.
Butterfly Network vs. Its Competitors
Artivion (NYSE:AORT) and Butterfly Network (NYSE:BFLY) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, media sentiment, earnings, analyst recommendations, profitability and risk.
Artivion has higher revenue and earnings than Butterfly Network. Artivion is trading at a lower price-to-earnings ratio than Butterfly Network, indicating that it is currently the more affordable of the two stocks.
86.4% of Artivion shares are held by institutional investors. Comparatively, 37.9% of Butterfly Network shares are held by institutional investors. 7.6% of Artivion shares are held by company insiders. Comparatively, 25.2% of Butterfly Network shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Artivion has a net margin of -4.43% compared to Butterfly Network's net margin of -71.79%. Artivion's return on equity of 5.70% beat Butterfly Network's return on equity.
In the previous week, Artivion had 28 more articles in the media than Butterfly Network. MarketBeat recorded 30 mentions for Artivion and 2 mentions for Butterfly Network. Artivion's average media sentiment score of 0.43 beat Butterfly Network's score of 0.00 indicating that Artivion is being referred to more favorably in the media.
Artivion has a beta of 1.64, suggesting that its share price is 64% more volatile than the S&P 500. Comparatively, Butterfly Network has a beta of 2.45, suggesting that its share price is 145% more volatile than the S&P 500.
Artivion presently has a consensus target price of $39.80, suggesting a potential downside of 7.36%. Butterfly Network has a consensus target price of $3.00, suggesting a potential upside of 113.52%. Given Butterfly Network's higher possible upside, analysts plainly believe Butterfly Network is more favorable than Artivion.
Summary
Artivion beats Butterfly Network on 12 of the 17 factors compared between the two stocks.
Get Butterfly Network News Delivered to You Automatically
Sign up to receive the latest news and ratings for BFLY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding BFLY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Butterfly Network Competitors List
Related Companies and Tools
This page (NYSE:BFLY) was last updated on 8/15/2025 by MarketBeat.com Staff
MarketBeat All Access